Large-scale testing (Phase 3)Not Yet RecruitingNCT07446335
What this trial is testing
A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma
Who this might be right for
Advanced Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 578